Literature DB >> 13032687

Management of Addison's disease in adrenalectomized patients.

D M BERGENSTAL, T L Y DAO.   

Abstract

Entities:  

Keywords:  ADDISON'S DISEASE; CORTISONE/therapeutic use; DESOXYCORTICOSTERONE/therapeutic use; HORMONES/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13032687      PMCID： PMC1877306     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  7 in total

1.  The effect of bilateral adrenalectomy upon neoplastic disease in man.

Authors:  C D WEST; V P HOLLANDER; W F WHITMORE; H T RANDALL; O H PEARSON
Journal:  Cancer       Date:  1952-09       Impact factor: 6.860

2.  Physiological effects of bilateral adrenalectomy in man.

Authors:  V P HOLLANDER; C D WEST; W F WHITMORE; H T RANDALL; O H PEARSON
Journal:  Cancer       Date:  1952-09       Impact factor: 6.860

3.  A study of bilateral total adrenalectomy in malignant hypertension and chronic nephritis; preliminary report.

Authors:  J H HARRISON; G W THORN; M G CRISCITIELLO
Journal:  J Urol       Date:  1952-04       Impact factor: 7.450

4.  Physiological changes following bilateral total adrenalectomy in patients with advanced hypertensive vascular disease.

Authors:  G W THORN; J H HARRISON; M G CRISCITIELLO; T F FRAWLEY
Journal:  Trans Assoc Am Physicians       Date:  1951

5.  Fibrinolysis in metastatic cancer of the prostate.

Authors:  H J TAGNON; W F WHITMORE; N R SHULMAN
Journal:  Cancer       Date:  1952-01       Impact factor: 6.860

6.  Surgery of the adrenals.

Authors:  C HUGGINS; D M BERGENSTAL
Journal:  J Am Med Assoc       Date:  1951-09-08

7.  Advances in the diagnosis and treatment of adrenal insufficiency.

Authors:  G W THORN; P H FORSHAM; T F FRAWLEY; D L WILSON; A E RENOLD; D S FREDRICKSON; D JENKINS
Journal:  Am J Med       Date:  1951-05       Impact factor: 4.965
  7 in total
  2 in total

1.  Studies of 17-hydroxycorticosteroids. V. Responses of 17-hydroxycorticosteroids, eosinophils, and glucose to ACTH and epinephrine.

Authors:  R S ELY; P F BRAY; R B RAILE; V C KELLEY
Journal:  J Clin Invest       Date:  1954-12       Impact factor: 14.808

2.  The lack of antitumor effects of o,p'DDA excludes its role as an active metabolite of mitotane for adrenocortical carcinoma treatment.

Authors:  Ségolène Hescot; Angelo Paci; Atmane Seck; Abdelhamid Slama; Say Viengchareun; Séverine Trabado; Sylvie Brailly-Tabard; Abir Al Ghuzlan; Jacques Young; Eric Baudin; Marc Lombès
Journal:  Horm Cancer       Date:  2014-07-16       Impact factor: 3.869
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.